English

EPOCH BIOSCIENCES INC

EDGAR

Quarterly report (10-Q) · filed 2004-11-15

36 filing records in this dataset, filed from 1996-05-10 to 2004-11-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.41 million USD

2004-09-30 · USD

Exact inputs and evidence

Revenue: 2405247 USD Source

Operating margin

-52.81%

2004-09-30 · %

Exact inputs and evidence

Operating Income: -1270203 USD Source
Revenue: 2405247 USD Source

Operating cash flow

-476 thousand USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1195669 USD Source
Operating Cash Flow: -719841 USD Source

Free cash flow

-538 thousand USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1195669 USD Source
Operating Cash Flow: -719841 USD Source
Capital Expenditure: 325502 USD Source
Capital Expenditure: 263046 USD Source

Cash and cash equivalents: 8.53 million USD 2004-09-30 Source
Exact value

8534534 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

8.3 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Revenue: 8901270 USD · 2003-01-01 – 2003-12-31 Source
Revenue: 6877709 USD · 2003-01-01 – 2003-09-30 Source
Revenue: 1933118 USD · 2004-01-01 – 2004-03-31 Source
Revenue: 1936837 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 2405247 USD · 2004-07-01 – 2004-09-30 Source

Net income

-2.04 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Net income: -4691862 USD · 2003-01-01 – 2003-12-31 Source
Net income: -4265755 USD · 2003-01-01 – 2003-09-30 Source
Net income: 174990 USD · 2004-01-01 – 2004-03-31 Source
Net income: -570474 USD · 2004-04-01 – 2004-06-30 Source
Net income: -1214848 USD · 2004-07-01 – 2004-09-30 Source

Operating cash flow

-1.23 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Operating cash flow: -277177 USD · 2003-01-01 – 2003-12-31 Source
Operating cash flow: -240971 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: -291396 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -719841 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -291396 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -1195669 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -719841 USD · 2004-01-01 – 2004-06-30 Source

Capital expenditure

363 thousand USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Capital expenditure: 435717 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 398125 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 48258 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 263046 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 48258 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 325502 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 263046 USD · 2004-01-01 – 2004-06-30 Source

Free cash flow

-1.59 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Operating cash flow: -277177 USD · 2003-01-01 – 2003-12-31 Source
Operating cash flow: -240971 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: -291396 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -719841 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -291396 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -1195669 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -719841 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 435717 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 398125 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 48258 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 263046 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 48258 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 325502 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 263046 USD · 2004-01-01 – 2004-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2004-11-15.

Financial data available through: 2003-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2003-12-31
Operating income: 9 of 11 periods available· newest 2003-12-31
Net income: 9 of 11 periods available· newest 2003-12-31
Operating cash flow: 9 of 11 periods available· newest 2003-12-31
Capital expenditure: 5 of 11 periods available· newest 2003-12-31
Total assets: 6 of 11 periods available· newest 2003-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2003-12-31
Current liabilities: 6 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-20.7%

Prior period

USD 11.23 million

2002-01-01 – 2002-12-31
Current period

USD 8.9 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

8901270 − 11225944 = -2324674 USD

11225944 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
8901270 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Year-over-year change in Revenue: -2324674 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 8901270 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#6014 Input fundies:Revenue: 11225944 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#6014
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.48 million

Prior period

−USD 3.22 million

2002-01-01 – 2002-12-31
Current period

−USD 4.69 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

-4691862 − -3215706 = -1476156 USD

-3215706 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-4691862 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Year-over-year change in Net income: -1476156 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4691862 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7041 Input fundies:NetIncome: -3215706 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7041
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.62 million

Prior period

−USD 3.9 million

2002-01-01 – 2002-12-31
Current period

−USD 277,177

2003-01-01 – 2003-12-31

Exact inputs and evidence

-277177 − -3895384 = 3618207 USD

-3895384 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-277177 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Year-over-year change in Operating cash flow: 3618207 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -277177 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 Input fundies:OperatingCashFlow: -3895384 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-55.6%

Prior period

USD 981,351

2002-01-01 – 2002-12-31
Current period

USD 435,717

2003-01-01 – 2003-12-31

Exact inputs and evidence

435717 − 981351 = -545634 USD

981351 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
435717 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Year-over-year change in Capital expenditure: -545634 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 435717 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 Input fundies:CapitalExpenditure: 981351 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 8.9 million 100% of revenue
Operating costs Derived USD 13.61 million 153% of revenue
Operating income −USD 4.71 million −53% of revenue
Tax, interest and other Derived −USD 20,777 −0.2% of revenue
Net income −USD 4.69 million −53% of revenue

Cash

Operating cash flow −USD 277,177 −3.1% of revenue
Capital expenditure USD 435,717 4.9% of revenue
Free cash flow Derived −USD 712,894 −8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 2,985% of revenue.
1999 Operating loss: operating costs were 2,187% of revenue.
2000 Operating loss: operating costs were 525% of revenue.
2001 Operating loss: operating costs were 167% of revenue.
2002 Operating loss: operating costs were 130% of revenue.
2003 Operating loss: operating costs were 153% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	159917	4774047 Derived	-4614130	488879 Derived	-5103009	Unavailable	Source 1998-01-01 – 1998-12-31: 159917 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -4614130 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -5103009 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -3756897 USD Inspect Operating Cash Flow Open source
1999 1999-01-01 – 1999-12-31	181094	3960170 Derived	-3779076	920878 Derived	-4699954	-3096955 Derived	Source 1999-01-01 – 1999-12-31: 181094 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -3779076 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -4699954 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -2855881 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 241074 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	1367053	7174792 Derived	-5807739	-912696 Derived	-4895043	-4957359 Derived	Source 2000-01-01 – 2000-12-31: 1367053 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -5807739 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -4895043 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -2650071 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 2307288 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	7521101	12527600 Derived	-5006499	-430350 Derived	-4576149	-3624492 Derived	Source 2001-01-01 – 2001-12-31: 7521101 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -5006499 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -4576149 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -2019345 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 1605147 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	11225944	14543849 Derived	-3317905	-102199 Derived	-3215706	-4876735 Derived	Source 2002-01-01 – 2002-12-31: 11225944 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -3317905 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -3215706 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -3895384 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 981351 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	8901270	13613909 Derived	-4712639	-20777 Derived	-4691862	-712894 Derived	Source 2003-01-01 – 2003-12-31: 8901270 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -4712639 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -4691862 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -277177 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 435717 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8.9M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	159917	Revenue: 159917 Open source
19991999-12-31	Revenue	181094	Revenue: 181094 Open source
20002000-12-31	Revenue	1367053	Revenue: 1367053 Open source
20012001-12-31	Revenue	7521101	Revenue: 7521101 Open source
20022002-12-31	Revenue	11225944	Revenue: 11225944 Open source
20032003-12-31	Revenue	8901270	Revenue: 8901270 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-20.7% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 159917 Open source
19991999-12-31	Year over year	13.2%	Revenue: 181094 Open source Revenue: 159917 Open source
20002000-12-31	Year over year	654.9%	Revenue: 1367053 Open source Revenue: 181094 Open source
20012001-12-31	Year over year	450.2%	Revenue: 7521101 Open source Revenue: 1367053 Open source
20022002-12-31	Year over year	49.3%	Revenue: 11225944 Open source Revenue: 7521101 Open source
20032003-12-31	Year over year	-20.7%	Revenue: 8901270 Open source Revenue: 11225944 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -52.9% 2003

Net margin -52.7% 2003

Free cash flow margin -8% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-2,885.3%	Operating Income: -4614130 Open source Revenue: 159917 Open source
19991999-12-31	Operating margin	-2,086.8%	Operating Income: -3779076 Open source Revenue: 181094 Open source
20002000-12-31	Operating margin	-424.8%	Operating Income: -5807739 Open source Revenue: 1367053 Open source
20012001-12-31	Operating margin	-66.6%	Operating Income: -5006499 Open source Revenue: 7521101 Open source
20022002-12-31	Operating margin	-29.6%	Operating Income: -3317905 Open source Revenue: 11225944 Open source
20032003-12-31	Operating margin	-52.9%	Operating Income: -4712639 Open source Revenue: 8901270 Open source
19981998-12-31	Net margin	-3,191%	Net Income: -5103009 Open source Revenue: 159917 Open source
19991999-12-31	Net margin	-2,595.3%	Net Income: -4699954 Open source Revenue: 181094 Open source
20002000-12-31	Net margin	-358.1%	Net Income: -4895043 Open source Revenue: 1367053 Open source
20012001-12-31	Net margin	-60.8%	Net Income: -4576149 Open source Revenue: 7521101 Open source
20022002-12-31	Net margin	-28.6%	Net Income: -3215706 Open source Revenue: 11225944 Open source
20032003-12-31	Net margin	-52.7%	Net Income: -4691862 Open source Revenue: 8901270 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 159917 Open source Operating Cash Flow: -3756897 Open source
19991999-12-31	Free cash flow margin	-1,710.1%	Revenue: 181094 Open source Operating Cash Flow: -2855881 Open source Capital Expenditure: 241074 Open source
20002000-12-31	Free cash flow margin	-362.6%	Revenue: 1367053 Open source Operating Cash Flow: -2650071 Open source Capital Expenditure: 2307288 Open source
20012001-12-31	Free cash flow margin	-48.2%	Revenue: 7521101 Open source Operating Cash Flow: -2019345 Open source Capital Expenditure: 1605147 Open source
20022002-12-31	Free cash flow margin	-43.4%	Revenue: 11225944 Open source Operating Cash Flow: -3895384 Open source Capital Expenditure: 981351 Open source
20032003-12-31	Free cash flow margin	-8%	Revenue: 8901270 Open source Operating Cash Flow: -277177 Open source Capital Expenditure: 435717 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -277.2K 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-3756897	Operating Cash Flow: -3756897 Open source
19991999-12-31	Operating cash flow	-2855881	Operating Cash Flow: -2855881 Open source
20002000-12-31	Operating cash flow	-2650071	Operating Cash Flow: -2650071 Open source
20012001-12-31	Operating cash flow	-2019345	Operating Cash Flow: -2019345 Open source
20022002-12-31	Operating cash flow	-3895384	Operating Cash Flow: -3895384 Open source
20032003-12-31	Operating cash flow	-277177	Operating Cash Flow: -277177 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -712.9K 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3756897 Open source
19991999-12-31	Free cash flow	-3096955	Operating Cash Flow: -2855881 Open source Capital Expenditure: 241074 Open source
20002000-12-31	Free cash flow	-4957359	Operating Cash Flow: -2650071 Open source Capital Expenditure: 2307288 Open source
20012001-12-31	Free cash flow	-3624492	Operating Cash Flow: -2019345 Open source Capital Expenditure: 1605147 Open source
20022002-12-31	Free cash flow	-4876735	Operating Cash Flow: -3895384 Open source Capital Expenditure: 981351 Open source
20032003-12-31	Free cash flow	-712894	Operating Cash Flow: -277177 Open source Capital Expenditure: 435717 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	Total Assets: 685467 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 20127048 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 20934762 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 17306223 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 15056166 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 10172684 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.5× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Current assets / current liabilities	0.07×	Current Assets: 323553 Open source Current Liabilities: 4404636 Open source
19991999-12-31	Current assets / current liabilities	18.32×	Current Assets: 18238725 Open source Current Liabilities: 995474 Open source
20002000-12-31	Current assets / current liabilities	4.52×	Current Assets: 12738130 Open source Current Liabilities: 2815179 Open source
20012001-12-31	Current assets / current liabilities	3.85×	Current Assets: 8437868 Open source Current Liabilities: 2191792 Open source
20022002-12-31	Current assets / current liabilities	1.99×	Current Assets: 6349404 Open source Current Liabilities: 3193284 Open source
20032003-12-31	Current assets / current liabilities	2.5×	Current Assets: 6071762 Open source Current Liabilities: 2428633 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	USD 6.66 million Exact value Exact value: 6658499 USD 1995-01-01 – 1995-12-31: 6658499 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 1995-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: 6658499 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6658499 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-97-000905.txt#2191 The citation records this snapshot. The page link may show a newer release later.	−USD 4.61 million Exact value Exact value: -4607871 USD 1995-01-01 – 1995-12-31: -4607871 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 1995-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -4607871 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4607871 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-97-000905.txt#2212 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 3.45 million Exact value Exact value: -3452158 USD 1996-01-01 – 1996-12-31: -3452158 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 1996-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -3452158 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3452158 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-98-001083.txt#1777 The citation records this snapshot. The page link may show a newer release later.	−USD 3.5 million Exact value Exact value: -3499732 USD 1996-01-01 – 1996-12-31: -3499732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 1996-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -3499732 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3499732 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-98-001083.txt#1788 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 3.6 million Exact value Exact value: -3604807 USD 1997-01-01 – 1997-12-31: -3604807 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 1997-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -3604807 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3604807 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-99-001009.txt#1579 The citation records this snapshot. The page link may show a newer release later.	−USD 3.35 million Exact value Exact value: -3353983 USD 1997-01-01 – 1997-12-31: -3353983 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 1997-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -3353983 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3353983 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-99-001009.txt#1593 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 5.1 million Exact value Exact value: -5103009 USD 1998-01-01 – 1998-12-31: -5103009 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 1998-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -5103009 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5103009 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0001095811-00-000820.txt#1963 The citation records this snapshot. The page link may show a newer release later.	−USD 3.76 million Exact value Exact value: -3756897 USD 1998-01-01 – 1998-12-31: -3756897 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 1998-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -3756897 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3756897 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0001095811-00-000820.txt#1978 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 4.7 million Exact value Exact value: -4699954 USD 1999-01-01 – 1999-12-31: -4699954 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 1999-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -4699954 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4699954 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-02-000629.txt#6634 The citation records this snapshot. The page link may show a newer release later.	−USD 2.86 million Exact value Exact value: -2855881 USD 1999-01-01 – 1999-12-31: -2855881 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 1999-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -2855881 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2855881 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-02-000629.txt#7039 The citation records this snapshot. The page link may show a newer release later.	USD 241,074 Exact value Exact value: 241074 USD 1999-01-01 – 1999-12-31: 241074 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EPOCH BIOSCIENCES INC · 1999-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Capital Expenditure: 241074 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 241074 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-02-000629.txt#7126 The citation records this snapshot. The page link may show a newer release later.	−USD 3.1 million Calculation and evidence -2855881 − 241074 USD Exact free cash flow: -3096955 USD 1999-01-01 – 1999-12-31: -2855881 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 241074 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EPOCH BIOSCIENCES INC · 1999-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Free cash flow: -3096955 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2855881 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-02-000629.txt#7039 Input fundies:CapitalExpenditure: 241074 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-02-000629.txt#7126 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 4.9 million Exact value Exact value: -4895043 USD 2000-01-01 – 2000-12-31: -4895043 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 2000-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -4895043 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4895043 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-03-000831.txt#6003 The citation records this snapshot. The page link may show a newer release later.	−USD 2.65 million Exact value Exact value: -2650071 USD 2000-01-01 – 2000-12-31: -2650071 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 2000-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -2650071 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2650071 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-03-000831.txt#6319 The citation records this snapshot. The page link may show a newer release later.	USD 2.31 million Exact value Exact value: 2307288 USD 2000-01-01 – 2000-12-31: 2307288 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EPOCH BIOSCIENCES INC · 2000-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Capital Expenditure: 2307288 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2307288 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-03-000831.txt#6434 The citation records this snapshot. The page link may show a newer release later.	−USD 4.96 million Calculation and evidence -2650071 − 2307288 USD Exact free cash flow: -4957359 USD 2000-01-01 – 2000-12-31: -2650071 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 2307288 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EPOCH BIOSCIENCES INC · 2000-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Free cash flow: -4957359 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2650071 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-03-000831.txt#6319 Input fundies:CapitalExpenditure: 2307288 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-03-000831.txt#6434 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 4.58 million Exact value Exact value: -4576149 USD 2001-01-01 – 2001-12-31: -4576149 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 2001-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -4576149 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4576149 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7041 The citation records this snapshot. The page link may show a newer release later.	−USD 2.02 million Exact value Exact value: -2019345 USD 2001-01-01 – 2001-12-31: -2019345 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 2001-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -2019345 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2019345 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 The citation records this snapshot. The page link may show a newer release later.	USD 1.61 million Exact value Exact value: 1605147 USD 2001-01-01 – 2001-12-31: 1605147 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EPOCH BIOSCIENCES INC · 2001-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Capital Expenditure: 1605147 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1605147 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 The citation records this snapshot. The page link may show a newer release later.	−USD 3.62 million Calculation and evidence -2019345 − 1605147 USD Exact free cash flow: -3624492 USD 2001-01-01 – 2001-12-31: -2019345 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 1605147 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EPOCH BIOSCIENCES INC · 2001-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Free cash flow: -3624492 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2019345 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 Input fundies:CapitalExpenditure: 1605147 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 3.22 million Exact value Exact value: -3215706 USD 2002-01-01 – 2002-12-31: -3215706 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 2002-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -3215706 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3215706 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7041 The citation records this snapshot. The page link may show a newer release later.	−USD 3.9 million Exact value Exact value: -3895384 USD 2002-01-01 – 2002-12-31: -3895384 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 2002-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -3895384 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3895384 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 The citation records this snapshot. The page link may show a newer release later.	USD 981,351 Exact value Exact value: 981351 USD 2002-01-01 – 2002-12-31: 981351 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EPOCH BIOSCIENCES INC · 2002-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Capital Expenditure: 981351 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 981351 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 The citation records this snapshot. The page link may show a newer release later.	−USD 4.88 million Calculation and evidence -3895384 − 981351 USD Exact free cash flow: -4876735 USD 2002-01-01 – 2002-12-31: -3895384 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 981351 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EPOCH BIOSCIENCES INC · 2002-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Free cash flow: -4876735 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3895384 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 Input fundies:CapitalExpenditure: 981351 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 4.69 million Exact value Exact value: -4691862 USD 2003-01-01 – 2003-12-31: -4691862 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Net Income: -4691862 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4691862 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7041 The citation records this snapshot. The page link may show a newer release later.	−USD 277,177 Exact value Exact value: -277177 USD 2003-01-01 – 2003-12-31: -277177 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Operating Cash Flow: -277177 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -277177 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 The citation records this snapshot. The page link may show a newer release later.	USD 435,717 Exact value Exact value: 435717 USD 2003-01-01 – 2003-12-31: 435717 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Capital Expenditure: 435717 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 435717 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 The citation records this snapshot. The page link may show a newer release later.	−USD 712,894 Calculation and evidence -277177 − 435717 USD Exact free cash flow: -712894 USD 2003-01-01 – 2003-12-31: -277177 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 435717 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EPOCH BIOSCIENCES INC · 2003-12-31 EPOCH BIOSCIENCES INC (edgar:910057) Free cash flow: -712894 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/910057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -277177 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7330 Input fundies:CapitalExpenditure: 435717 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910057/0000892569-04-000407.txt#7423 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000910057, 910057, edgar:910057

Also known as EPOCH PHARMACEUTICALS INC, MICROPROBE CORP /DE/

EPOCH BIOSCIENCES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation